Advertisement
Screener

Keros Therapeutics, Inc. (KROS) Income Taxes Paid

2.5 / 5 stars · 26/51 Roast Me

Keros Therapeutics, Inc. Income Taxes Paid

Keros Therapeutics, Inc. (KROS) reported Income Taxes Paid of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-03.

Financial Statements › Cash Flow › Other Cash Flow Items

us-gaap:IncomeTaxesPaidNet · last filed 2026-08-03

  • Keros Therapeutics, Inc. income taxes paid, net for fiscal 2025 was $7.14M.
  • Keros Therapeutics, Inc. income taxes paid, net for fiscal 2024 was $0.00.
  • Keros Therapeutics, Inc. income taxes paid, net for fiscal 2020 was $0.00, a 100.00% decline from fiscal 2019.
  • Keros Therapeutics, Inc. income taxes paid, net for fiscal 2019 was $256.00K.
Period endIncome Taxes Paid, Net 6 monthIncome Taxes Paid, Net 12 month
2026-06-30$0.00
10-Q · filed 2026-08-03
2025-12-31$7.14M
10-K · filed 2026-03-04
2025-06-30$1.50M
10-Q · filed 2026-08-03
2024-12-31$0.00
10-K · filed 2026-03-04
2020-12-31$0.00
10-K · filed 2021-03-25
2019-12-31$256.00K
10-K · filed 2021-03-25

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cartesian Therapeutics, Inc. (RNAC)United States$0.231B-2.04
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73